55.20 -0.19 (-0.34%)
After hours: 7:47PM EDT
|Bid||55.01 x 800|
|Ask||55.38 x 800|
|Day's Range||55.08 - 56.17|
|52 Week Range||51.93 - 82.15|
|Beta (3Y Monthly)||1.21|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 30, 2019 - May 6, 2019|
|Forward Dividend & Yield||2.00 (3.57%)|
|1y Target Est||76.76|
Yahoo Finance's Zack Guzman and Seana Smith are joined by Beth Comstock, Former GE Vice Chair, “Imagine it Forward” author to discuss the healthiest communities in America with Dr. Garth Graham, Aetna Foundation president.
In this week's Family First segment on YFI PM, we break down new concerns over kale, tax refunds, and the latest break-through for postpartum depression.
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
NEW YORK, NY / ACCESSWIRE / March 26, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation (''CVS'' or the ''Company'') (CVS) and certain of its officers and directors. The class action, filed in United States District Court, Southern District of New York, and indexed under 19-cv-01725, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise acquired CVS Health securities between May 21, 2015 and February 20, 2019, both dates inclusive (the ''Class Period''), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the ''Exchange Act'') and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Apple (AAPL) and Amazon (AMZN) are two of the largest companies on the planet. The tech powers have reshaped industries and changed the way millions of people function on a daily basis. But today, Apple and Amazon face possible transition periods as they try to expand their offerings to drive growth. So which stock, AAPL or AMZN, is a better buy?
NEW YORK, NY / ACCESSWIRE / March 26, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of CVS Health Corporation (CVS) from May 21, 2015 through February 20, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for CVS investors under the federal securities laws. If you wish to serve as lead plaintiff, you must move the Court no later than April 26, 2019.
Investing.com - The Trump Administration wants the entire Affordable Care Act (also known as Obamacare) declared unconstitutional and Cigna (NYSE:CI) shares fell back Tuesday as a result.
How Amazon and Alibaba Are Facing Competition(Continued from Prior Part)Amazon not done shaking up the pharmacy space Amazon (AMZN) recently began letting customers use funds in their special healthcare savings account to pay for purchases of
The tenant just opened its largest location to date in one of the most expensive — yet challenging — neighborhoods in San Francisco.
The Insider Monkey team has completed processing the quarterly 13F filings for the December quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors endured a torrid quarter, which certainly propelled them to adjust their equity holdings so as to maintain the desired risk profile. As […]
What do a beaten-down biotech, a giant pharmacy chain, and a robotic surgical systems maker have in common? They could all be great stocks to buy.
NEW YORK, March 25, 2019 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.
NEW ORLEANS, March 25, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
NEW YORK, March 25, 2019 -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a.
What Drove Curaleaf’s Stock Price Last Week?Sector performance On March 22, the US market fell on concerns over global growth prospects as the yield on long-term bonds, such as the ten-year Treasury note, fell below that of short-term bonds, such
NEW YORK, March 25, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.
The smart money is buying these three stocks, but does that make them right for your portfolio? It's a matter of balancing risk and reward...
NEW ORLEANS, March 22, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
CVS Health will be presenting three Alabama colleges with grants to advocate for, adopt and implement smoke- and tobacco- free campus policies. Lawson State Community College in Birmingham, Lurleen B. Wallace Community College and Andalusia and the University of West Alabama in Livingston will receive a total of $59,786 in grants from the CVS Health Foundation. “A critical goal in building healthier communities across the country is reducing tobacco-use, which remains one of the leading causes of preventable death in this country,” said Eileen Howard Boone, president of the CVS Health Foundation.
CVS (NYSE:CVS) announced that it will soon start selling CBD products in 800 stores and eight states.Source: Mike Mozart via FlickrCBD refers to cannabidiol, which is a hemp-based product that is part of the cannabis family, but differs from marijuana as the latter has TCH, which is the psychoactive chemical in the plant. Meanwhile, CBD is not psychoactive, meaning it does not incapacitate it users and may have medicinal benefits.CVS said Wednesday that it will start selling CBD products, including creams, sprays and roll-ons, which will serve as "an alternative source of relief." Some believe the substance helps with anxiety, pain, inflammation and cancer, although the research to back up this claims is anecdotal-the only FDA-backed CBD oil helps with seizures for severe forms of epilepsy.InvestorPlace - Stock Market News, Stock Advice & Trading Tips"We are carrying hemp-derived CBD products in select states to help meet consumer demand for alternative care options," said CVS Health Spokesperson, Mike DeAngelis. The company will partner up with a company to test the quality of the CBD products available in its drug stores.Only consumers in the states of Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee will have access to these products at their local CVS locations at first. Claims surrounding how effective these CVS CBD products are will vary from item to item.CVS stock is down about 1.6% on Friday following the news. More From InvestorPlace * 5 Cloud Stocks to Help Your Portfolio Fly * 10 Stocks on the Rise Heading Into the Second Quarter * 7 Beaten-Up Stocks to Buy as They Reverse Course Compare Brokers The post CVS to Sell CBD Products in 800 Stores -- What and Where? appeared first on InvestorPlace.